Matthew J. Rubin

Advisor - Faegre Baker Daniels Consulting

Overview

Matt Rubin assists clients across various sectors of the health care industry on strategic engagements, state and federal government relations, and public policy development and implementation. Matt drives public policy strategies and solutions for nonprofit patient advocacy groups, coalitions, integrated health systems, domestic and international biopharmaceutical companies, and various other health care policy stakeholders. His background in clinical research and biological sciences gives him an insider’s perspective on the challenges and objectives of many of his clients.
Matt has particular expertise in issues related to:
  • Internet pharmacies and pharmaceutical supply chain security.
  • The convergence of the internet, health care, technology and policy.
  • Digital health, including telemedicine, telehealth and mobile health applications.
  • Internet governance and ICANN policy.
  • Development of a comprehensive and coordinated solution to the United States’ prescription opioid epidemic.
  • Health care regulations.
  • Coverage and reimbursement.

For more on these issues, check out the Digital Health Law and Policy LinkedIn Group that Matt helps lead.

Collaborating With Key Federal Stakeholders

Matt conducts outreach with key federal departments and agencies involved in health care-related issues, including:
  • Centers for Disease Control and Prevention (CDC)
  • Centers for Medicare & Medicaid Services (CMS)
  • Department of Commerce (DOC)
  • Department of Health and Human Services (HHS)
  • Department of Justice (DOJ)
  • Executive Office of the President (EOP)
  • Food & Drug Administration (FDA)
  • National Institutes of Health (NIH) and the National Institute on Drug Abuse (NIDA)
  • State Department
  • U.S. Congress
  • U.S. Patent and Trademark Office (USPTO)
  • U.S. Trade Representative

Matt also participates in international policy development and implementation, which allows him to engage with key policymakers and regulators throughout Canada, Europe, Asia and elsewhere on health care-related issues.

Clinical Research Experience

Before joining Faegre Baker Daniels, Matt was engaged in cutting-edge cancer treatment research, with a particular focus on drug development, biomarker discovery and validation, and novel therapies. Matt worked to develop a comprehensive oncologic tissue biorepository and clinical database and was responsible for developing and implementing clinical trial site designs and research protocols across various sites within the U.S.
 
Matt is a consulting professional within Faegre Baker Daniels Consulting, and does not act as a lawyer for clients. Learn more about the Faegre Baker Daniels Consulting practice.

Credentials

Education

University of Maryland
B.S. Biological Sciences with specialization in Neurobiology and Physiology (2013)

Insights & Events

Other Perspectives
  • Verified Top-Level Domains
    Panelist, ICANN's Public Safety Working Group, March 2017
  • The Alliance for Safe Online Pharmacy
    Presenter, ICANN Generic Names Supporting Organization Joint Meeting of the Registries and Registrars Stakeholder Groups, March 2017

Leadership & Community

Pro Bono

  • International Refugee Assistance Program — Assist Faegre Baker Daniels law associates with pro bono cases

Civic Activities

  • Make-A-Wish Foundation, University of Maryland — Maryland Wishes, Co-Creative Director
  • Make-A-Wish Foundation, Mid Atlantic — Community Leadership Council Member
  • Faegre Baker Daniels — Community Service Volunteer
The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.